Traditional Chinese medicine composition for treating hyperosteogeny
The invention relates to a traditional Chinese medicine composition for treating hyperosteogeny. The traditional Chinese medicine composition is prepared from the following active pharmaceutical ingredients in parts by weight: 15-25 parts of carthamus tinctorius, 15-25 parts of common goldenrod herb...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to a traditional Chinese medicine composition for treating hyperosteogeny. The traditional Chinese medicine composition is prepared from the following active pharmaceutical ingredients in parts by weight: 15-25 parts of carthamus tinctorius, 15-25 parts of common goldenrod herb, 15-25 parts of radix sophorae flavescentis, 10-15 parts of radix cyathulae, 10-15 parts of rhizoma drynariae, 10-15 parts of giant knotweed, 10-15 parts of dragon's blood, 5-10 parts of long pepper, 10-15 parts of desertliving cistanche, 10-15 parts of radix codonopsitis, 5-10 parts of clematis root, 5-10 parts of grassleaf sweelflag rhizome, 5-10 parts of herba lycopodii, 5-10 parts of cassia twig and 5-10 parts of fructus psoraleae. The traditional Chinese medicine composition has the efficacies of activating blood circulation to dissipate blood stasis, dredging collaterals to relieve pain, tonifying the liver and kidney, strengthening tendons and bones, dispelling wind and cold, clearing heat to remove toxicity, and invigorating spleen-stomach and replenishing qi, can be utilized for treating hyperosteogeny as well as cervical spondylosis, lumbago, skelalgia, limb numbness, intervertebral disc protrusion, scapulohumeral periarthritis, lumbar muscle strain and the like, and is free from toxic or side effect and remarkable in treatment effect. |
---|